Disease relevance of d-eritadenine

• Dietary eritadenine suppresses guanidinoacetic Acid-induced hyperhomocysteinemia in rats [1].
• Although eritadenine caused fatty liver when added to the diets containing 0 or 2 g/kg choline chloride, a high level (8 g/kg) of choline chloride fully prevented the eritadenine-induced fatty liver without diminution of hypocholesterolemic action [2].

High impact information on d-eritadenine

• The disposition of endogenously formed L-homocysteine was investigated in isolated rat hepatocytes and nontransformed and malignant C3H/10T1/2 mouse embryo fibroblasts exposed to 3-deazaaristeromycin or D-eritadenine, compounds which are potent inhibitors of AdoHcy hydrolase [3].
• D-eritadenine (DEA) is a potent inhibitor (IC(50) = 7 nm) of S-adenosyl-l-homocysteine hydrolase (AdoHcyase) [4].
• The results confirm that GAA is a useful compound to induce experimental hyperhomocysteinemia and indicate that eritadenine can effectively counteract the hyperhomocysteinemic effect of GAA [1].
• We assessed the effect of eritadenine, a hypocholesterolemic factor isolated from the edible mushroom Lentinus edodes, on plasma homocysteine concentration using methyl-group acceptor-induced hyperhomocysteinemic rats [1].
• The activities of the Delta5-, Delta6- and Delta9-desaturases in liver microsomes were significantly decreased by eritadenine and ethanolamine; there was a significant correlation between the activity of Delta5- or Delta6-desaturase and the proportion of PE in the total phospholipids or the PC/PE ratio [5].

Chemical compound and disease context of d-eritadenine

• Suppression of methionine-induced hyperhomocysteinemia by dietary eritadenine in rats [6].

Biological context of d-eritadenine

• In this study, the time-dependent effects of dietary eritadenine on several variables concerning lipid metabolism were investigated in rats to clarify the sequence of metabolic changes caused by eritadenine, with special interest in the association of the liver microsomal phospholipid profile and the activity of Delta6-desaturase [7].

Associations of d-eritadenine with other chemical compounds

• The hypocholesterolemic action of eritadenine, a compound found in the mushroom Lentinus edodes, was investigated in relation to its influence on phospholipid metabolism in the liver of rats fed diets containing different amounts of choline chloride (0, 2 and 8 g/kg diet) [2].
• The effects of eritadenine, a constituent of the Lentinus edodes mushroom, and ethanolamine, the base constituent of phosphatidylethanolamine (PE), on fatty acid desaturase activities and lipid profiles were investigated comparatively in rats [5].
• Effects of dietary eritadenine on liver microsomal delta6-desaturase activity and the fatty acid profile of phosphatidylcholine, cholesteryl esters, and triglycerides of liver microsomes or plasma were investigated in rats fed different fats (palm oil, olive oil, and safflower oil) [8].

Gene context of d-eritadenine

• The inhibitory effect of eritadenine was resistant to adenosine deaminase [9].

References